Across TCGA pan-cancer cohorts, RPL7P45 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL7P45’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RPL7P45 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7P45 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

HNSC, KIRC, and THCA are the cancer types where RPL7P45 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7P45 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	IV	+0.054	.002	7	view →
KIRC	Female	III,IV	−0.039	.045	2	view →
THCA	Female	II,III,IV	+0.025	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RPL7P45 RNA expression & survival · all RPL7P45 data types